• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Director Kerrey J Robert sold $201,581 worth of shares (1,222 units at $164.96), decreasing direct ownership by 5% to 22,377 units (SEC Form 4)

    5/28/25 8:00:05 PM ET
    $THC
    Hospital/Nursing Management
    Health Care
    Get the next $THC alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    KERREY J ROBERT

    (Last) (First) (Middle)
    14201 DALLAS PARKWAY

    (Street)
    DALLAS TX 75254

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    TENET HEALTHCARE CORP [ THC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/27/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/27/2025 S 1,222 D $164.96(1) 22,377 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $164.48 to $165.25.
    Chad J. Wiener, as Attorney-in-Fact for J. Robert Kerrey 05/28/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $THC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $THC

    DatePrice TargetRatingAnalyst
    7/28/2025Outperform → Peer Perform
    Wolfe Research
    5/29/2025$195.00Equal Weight → Overweight
    Wells Fargo
    4/15/2025$137.00Outperform → Neutral
    Robert W. Baird
    3/26/2025$165.00Overweight
    Morgan Stanley
    2/26/2025$175.00Buy
    TD Cowen
    12/17/2024$175.00Overweight
    Analyst
    12/16/2024$196.00 → $140.00Buy → Neutral
    Goldman
    11/25/2024$205.00 → $150.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $THC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tenet and USPI Named Foundational Sponsor of Inaugural AAOS Launchpad Program

    Strategic partnership aims to empower PGY5 orthopaedic residents with critical tools, mentorship, and resources for a successful transition into practice ROSEMONT, Ill., Aug. 20, 2025 /PRNewswire/ -- The American Association of Orthopaedic Surgeons (AAOS) announced that Tenet Healthcare (Tenet) and United Surgical Partners International (USPI) have joined as a foundational sponsor of the inaugural AAOS Launchpad Program. This strategic collaboration underscores a shared commitment to supporting early-career orthopaedic surgeons and driving transformative solutions in musculoskeletal healthcare.

    8/20/25 1:03:00 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet Reports Strong Second Quarter 2025 Results; Raises 2025 Financial Outlook

    Net income available to common shareholders in second quarter 2025 was $288 million, or $3.14 per diluted share Adjusted diluted earnings per share1 increased 74% to $4.02 in second quarter 2025 compared to $2.31 in second quarter 2024 Consolidated Adjusted EBITDA1 in second quarter 2025 increased 18.6% to $1.121 billion compared to second quarter 2024; Second quarter 2025 Adjusted EBITDA margin was 21.3% Second quarter 2025 Ambulatory Care Adjusted EBITDA of $498 million increased 11.4% over second quarter 2024 Board of Directors authorized a $1.5 billion increase to the share repurchase program FY 2025 Adjusted EBITDA Outlook is now expected to be in the range of $4.40 bil

    7/22/25 6:45:00 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet to Report its Second Quarter 2025 Results on July 22nd

    Tenet Healthcare Corporation (NYSE:THC) will release its second quarter 2025 results before the market opens on Tuesday, July 22nd, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. W

    6/23/25 9:00:00 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    $THC
    SEC Filings

    View All

    SEC Form 10-Q filed by Tenet Healthcare Corporation

    10-Q - TENET HEALTHCARE CORP (0000070318) (Filer)

    7/29/25 8:19:04 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet Healthcare Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - TENET HEALTHCARE CORP (0000070318) (Filer)

    7/22/25 6:46:17 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet Healthcare Corporation filed SEC Form 8-K: Leadership Update

    8-K - TENET HEALTHCARE CORP (0000070318) (Filer)

    6/5/25 4:06:46 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    $THC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Sutaria Saumya was granted 106,682 shares, increasing direct ownership by 29% to 475,365 units (SEC Form 4)

    4 - TENET HEALTHCARE CORP (0000070318) (Issuer)

    8/15/25 8:00:05 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    EVP & Chief Financial Officer Park Sun converted options into 20,707 shares and covered exercise/tax liability with 8,813 shares, increasing direct ownership by 443% to 14,579 units (SEC Form 4)

    4 - TENET HEALTHCARE CORP (0000070318) (Issuer)

    8/15/25 8:00:11 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Director Fisher Richard W sold $144,762 worth of shares (836 units at $173.16), decreasing direct ownership by 7% to 11,292 units (SEC Form 4)

    4 - TENET HEALTHCARE CORP (0000070318) (Issuer)

    6/6/25 8:00:07 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    $THC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tenet Healthcare downgraded by Wolfe Research

    Wolfe Research downgraded Tenet Healthcare from Outperform to Peer Perform

    7/28/25 8:36:14 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet Healthcare upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Tenet Healthcare from Equal Weight to Overweight and set a new price target of $195.00

    5/29/25 8:14:10 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet Healthcare downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Tenet Healthcare from Outperform to Neutral and set a new price target of $137.00

    4/15/25 9:28:30 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    $THC
    Financials

    Live finance-specific insights

    View All

    Tenet to Report its Second Quarter 2025 Results on July 22nd

    Tenet Healthcare Corporation (NYSE:THC) will release its second quarter 2025 results before the market opens on Tuesday, July 22nd, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. W

    6/23/25 9:00:00 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet to Report Its First Quarter 2025 Results on April 29th

    Tenet Healthcare Corporation (NYSE:THC) will release its first quarter 2025 results before the market opens on Tuesday, April 29, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We als

    4/9/25 9:00:00 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet to Report its Fourth Quarter 2024 Results on February 12th

    Tenet Healthcare Corporation (NYSE:THC) will release its fourth quarter 2024 results before the market opens on Wednesday, February 12, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospital

    1/13/25 9:00:00 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    $THC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Tenet Healthcare Corporation

    SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)

    11/14/24 4:17:18 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Tenet Healthcare Corporation

    SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)

    11/14/24 1:22:34 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by Tenet Healthcare Corporation

    SC 13G - TENET HEALTHCARE CORP (0000070318) (Subject)

    11/12/24 10:34:15 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    $THC
    Leadership Updates

    Live Leadership Updates

    View All

    Tenet Healthcare Appoints Vineeta Agarwala to Board of Directors

    Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Vineeta Agarwala, M.D., PhD, to its Board of Directors, effective immediately. Dr. Agarwala will serve as a member of the Quality, Compliance, and Ethics Committee, as well as the Human Resources Committee, increasing the size of the Board to 13 directors. "We are pleased to welcome Dr. Vineeta Agarwala to the Tenet Board," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "Vineeta is a leader in healthcare in her own right. Her expertise in innovative technologies, including applications of artificial intelligence will enhance our governance in a rapidly evolving healthcare marketplace." Dr

    12/13/23 4:05:00 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet Healthcare Appoints Senator Roy Blunt to Board of Directors

    Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Senator Roy Blunt to the Tenet Board of Directors, effective immediately. Senator Blunt will serve as a member of the Audit Committee, Nominating and Corporate Governance Committee, and Environmental, Social, and Governance Committee. This appointment expands the Board to 12 directors, 11 of whom are independent members. "We are pleased to welcome Senator Roy Blunt as a new board member," said Saum Sutaria, M.D., Chief Executive Officer of Tenet. "With more than 25 years of legislative experience, Roy's expertise in public policy and addressing cross-cutting issues will be invaluable to helping Tenet make a lasting

    8/10/23 4:05:00 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet Healthcare Names CEO Saum Sutaria as Chairman of the Board

    Tenet Healthcare Corporation (NYSE:THC) today announced that its Board of Directors has elected Chief Executive Officer, Saum Sutaria, M.D., to assume the additional position of Chairman, effective immediately. Sutaria succeeds Senator J. Robert Kerrey, who will transition to Lead Director of the Board, a role he previously held from 2017- 2022. Sutaria has served as Tenet Healthcare's CEO since September 2021 and a member of the Board of Directors since 2020. Previously, he served as the Company's Chief Operating Officer. "The appointment of Saum to Chairman is a testament to his steadfast leadership and commitment to Tenet Healthcare," said Senator J. Robert Kerrey, Lead Director. "Th

    8/10/23 6:45:00 AM ET
    $THC
    Hospital/Nursing Management
    Health Care